Erick Lucera - Mar 31, 2025 Form 3 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role: Chief Financial Officer
Signature: /s/ Ron Caponigro, Attorney-in-Fact
Stock symbol: DYN
Transactions as of: Mar 31, 2025
Transactions value $: $0
Form type: 3
Date filed: 4/1/2025, 04:31 PM
Previous filing: Mar 28, 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney